title: Modification of tamoxifen response: what have we learned?
authors: Timothy L
authors: TL
authors: Lash
authors: Thomas P
authors: TP
authors: Ahern
authors: Deirdre
authors: D
authors: Cronin-Fenton
authors: Jens Peter
authors: JP
authors: Garne
authors: Stephen
authors: S
authors: Hamilton-Dutoit
authors: Marianne Ewertz
authors: ME
authors: Kvistgaard
authors: Carol L
authors: CL
authors: Rosenberg
authors: Rebecca A
authors: RA
authors: Silliman
authors: Henrik Toft
authors: HT
authors: Sørensen
mesh_terms: D000483:Alleles; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000235:genetics; D017024:Chemotherapy, Adjuvant; D019389:Cytochrome P-450 CYP2D6 / Q000235:genetics*; D019008:Drug Resistance, Neoplasm / Q000235:genetics*; D005260:Female; D006801:Humans; D010597:Pharmacogenetics; D011960:Receptors, Estrogen / Q000378:metabolism; D020845:Selective Estrogen Receptor Modulators / Q000378:metabolism / Q000627:therapeutic use*; D013629:Tamoxifen / Q000378:metabolism / Q000627:therapeutic use*
chemical_list: D011960:Receptors, Estrogen; D020845:Selective Estrogen Receptor Modulators; D013629:Tamoxifen; D019389:Cytochrome P-450 CYP2D6